Oprea, Tudor I.
Bologa, Cristian G.
Brunak, Søren
Campbell, Allen
Gan, Gregory N.
Gaulton, Anna
Gomez, Shawn M.
Guha, Rajarshi
Hersey, Anne
Holmes, Jayme
Jadhav, Ajit
Jensen, Lars Juhl
Johnson, Gary L.
Karlson, Anneli
Leach, Andrew R.
Ma'ayan, Avi
Malovannaya, Anna
Mani, Subramani
Mathias, Stephen L.
McManus, Michael T.
Meehan, Terrence F.
von Mering, Christian
Muthas, Daniel
Nguyen, Dac-Trung
Overington, John P.
Papadatos, George
Qin, Jun
Reich, Christian
Roth, Bryan L.
Schürer, Stephan C.
Simeonov, Anton
Sklar, Larry A.
Southall, Noel
Tomita, Susumu
Tudose, Ilinca
Ursu, Oleg
Vidović, Dušica
Waller, Anna
Westergaard, David
Yang, Jeremy J.
Zahoránszky-Köhalmi, Gergely
Article History
First Online: 23 March 2018
Change Date: 23 March 2018
Change Type: Correction
Change Details: In the version of this article that was originally published online, an older version of the data set categorizing proteins into target development levels was used to create Figure 1 than the version used to create Table 1, and data from Figure 1 were referred to at several points in the text of the article. Figure 1 and the associated text have been updated to match Table 1 in the online and print versions of the article. The authors apologize for any inconvenience that this error may have caused.
Competing interests
: S.B. and L.J.J. are co-founders, shareholders and scientific advisory board members of Intomics A/S, an omics data integration company. A.C. and C.R. are employees of IQVIA, a company serving the combined industries of health information technologies and clinical research. I.T. is a current employee of Google Germany. G.P. is a current employee of GlaxoSmithKline, a global health-care company. D.M. is a current employee of AstraZeneca, a global, research-based biopharmaceutical company. J.P.O. is currently an employee of Medicines Discovery Catapult, a UK government-funded facility for collaborative research and development.